Skip to main content

COVID-19 treatment: Gilead Sciences Pty Ltd, remdesivir (VEKLURY)

On 10 July 2020 the Therapeutic Goods Administration (TGA) granted provisional approval to remdesivir ("Veklury", Gilead Sciences Pty Ltd) as the first treatment option for COVID-19

Published
Last updated

Related content

Help us improve this page

This form is anonymous. If you would like a response from us, please visit Contact us.